Odds of hep C recurrence ‘low’ after achieving SVR, even in high-risk groups
Patients treated with direct-acting antivirals are more likely to acquire a new infection than relapse, data show.
Tag: DAAs
Patients treated with direct-acting antivirals are more likely to acquire a new infection than relapse, data show.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
